India News3 years ago
AIIMS Delhi to begin screening children aged 2-18 years for Covaxin trials from today
The All India Institute of Medical Sciences (AIIMS) Delhi will start screening children for clinical trials of Covaxin, the Covid-19 vaccine developed by Bharat Biotech and...